Skip to main content
SpringerLink
Log in

Trends in the pathophysiology and pharmacotherapy of spasticity

  • Editorial
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Summary

Spasticity develops after supraspinal or spinal lesions of descending motor systems, with obligate involvement of the corticospinal tract. Spasticity is characterized by an increase in muscle tone, which, in contrast to many other types of enhanced muscle tone, shows a marked velocity-dependent increase when the muscle is passively stretched. The pathophysiological mechanisms underlying this spastic muscle tone remain obscure. Three major causes are currently considered possible: (1) changes in the excitability of spinal interneurones; (2) receptor hypersensitivity; (3) formation of new synapses by sprouting. The latter mechanism could account for the long time course over which spastic muscle tone develops in hemiplegic or paraplegic patients, but there is no experimental evidence for this hypothesis. The electromyographic (EMG) gait analysis of patients with spasticity has thrown doubt on the common belief that the velocity-dependent increase in spastic muscle tone is evoked by stretch reflex activity and has led to the idea that spastic muscle tone resides in the muscle fibres themselves. While such a mechanism may contribute to the slowness of active movements in spastic patients, recent experiments on patients with spastic arm paresis have confirmed the classical view that the spastic muscle tone is related to the EMG activity evoked in the passively stretched muscle. This pathological EMG activity is seen during the entire range of the dynamic phase of the stretch, during which a normal muscle exhibits only an early, phasic burst at the highest stretch velocities employed. For the pharmacological treatment of spasticity, substances with different central or peripheral actions are available. Their assumed receptor actions are described, together with their main indications and side-effects. A new way to treat severe spasticity is the continuous intrathecal application of baclofen via an implantable pump. This application has the benefit that the sedative effect of baclofen when applied in high oral dosage is avoided.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ahlquist G, Landin S, Wroblewski R (1975) Ultrastructure of skeletal muscle in patients with Parkinson's disease and upper motor lesions. Lab Invest 32:673

    Google Scholar 

  2. Ashby P, Wiens M (1989) Reciprocal inhibition following lesions of the spinal cord in man. J Physiol (Lond) 414:145–157

    Google Scholar 

  3. Ault B, Nadler JV (1982) Baclofen selectively inhibits transmission at synapses made by axons of CA1 pyramidal cells in the hippocampal slice. J Pharmacol Exp Ther 223:291–297

    Google Scholar 

  4. Benecke R (1987) Spasticity/spasms: clinical aspects and treatment. In: Benecke R, Conrad B, Marsden CD (eds) Motor disturbances 1. Academic Press, London, pp 169–177

    Google Scholar 

  5. Benecke R, Conrad B, Meinck HM, Höhne J (1983) Electromyographic analysis of bicycling on an ergometer for evaluation of spasticity of lower limbs in man. In: Desmedt JE (ed) Motor control mechanisms in health and disease. Raven Press, New York, pp 1035–1046

    Google Scholar 

  6. Berger W, Horstmann G, Dietz V (1984) Tension development and muscle activation in the leg during gait in spastic hemiparesis: independence of muscle hypertonia and exaggerated stretch reflexes. J Neurol Neurosurg Psychiatry 47:1029–1033

    Google Scholar 

  7. Berger W, Horstmann G, Dietz V (1988) Spastic paresis: impaired spinal reflexes and intact motor programs. J Neurol Neurosurg Psychiatry 51:568–571

    Google Scholar 

  8. Bormann J (1988) Electrophysiology of GABAA and GABAB receptor subtypes. Trends Neurol Sci 11:112–116

    Google Scholar 

  9. Bormann J (1988) Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur J Pharmacol 166:591–592

    Google Scholar 

  10. Burke D (1983) Critical examination of the case for or against fusimotor involvement in disorders of muscle tone. In: Desmedt JE (ed) Motor control mechanisms in health and disease. Raven Press, New York, pp 133–150

    Google Scholar 

  11. Burke D, Gillies JD, Lance JW (1970) The quadriceps stretch reflex in human spasticity. J Neurol Neurosurg Psychiatry 33:216–223

    Google Scholar 

  12. Burke D, Knowles L, Andrews CJ, Ashby P (1972) Spasticity, decerebrate rigidity, and the clasp-knife phenomenon: an experimental study in the cat. Brain 95:31–48

    Google Scholar 

  13. Chapman CE, Wiesendanger M (1982) Recovery of function following unilateral lesions of the bulbar pyramid in the monkey. Electroencephalogr Clin Neurophysiol 53:374–387

    Google Scholar 

  14. Chen DF, Bianchetti M, Wiesendanger M (1987) Involvement of noradrenergic systems in the modulation of cutaneous reflexes. In: Benecke R, Conrad B, Marsden CD (eds) Motor disturbances 1. Academic Press, London, pp 179–186

    Google Scholar 

  15. Conrad B, Benecke R, Meinck HM (1985) Gait disturbances in paraspastic patients. In: Delwaide PJ, Young RR (eds) Clinical neurophysiology in spasticity. Elsevier, Amsterdam, pp 155–174

    Google Scholar 

  16. Davidoff RA (1985) Antispasticity drugs: mechanisms of action. Ann Neurol 17:107–116

    Google Scholar 

  17. Deisz RS, Lux HD (1985) Gamma-aminobutyric acid-induced depression of calcium currents of chick sensory neurons. Neurosci Lett 56:205–210

    Google Scholar 

  18. Delwaide PJ, Olivier E (1987) Pathophysiological aspects of spasticity in man. In: Benecke R, Conrad B, Marsden CD (eds) Motor disturbances 1. Academic Press, London, pp 153–167

    Google Scholar 

  19. Delwaide PJ, Oliver E (1988) Short-latency autogenic inhibition (IB inhibition) in human spasticity. J Neurol Neurosurg Psychiatry 51:1546–1550

    Google Scholar 

  20. Dietz V (1987) Role of peripheral afferents and spinal reflexes in normal and impaired human locomotion. Rev Neurol (Paris) 143:241–254

    Google Scholar 

  21. Dietz V, Quintern J, Berger W (1981) Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia. Brain 104:431–449

    Google Scholar 

  22. Dietz V, Ketelsen UP, Berger W. Quintern J (1986) Motor unit involvement in spastic paresis. Relationship between leg muscle activation and histochemistry. J Neurol Sci 75:89–103

    Google Scholar 

  23. Dutar P, Nicoll RA (1988) A physiological role for GABAB receptors in the central nervous system. Nature 332:156–158

    Google Scholar 

  24. Edgley SA, Jankowska E (1987) An interneuronal relay for group I and II muscle afferents in the midlumbar segments of the cat spinal cord. J Physiol (Lond) 389:647–674

    Google Scholar 

  25. Edström L (1970) Selective changes in the size of red and white muscle fibres in upper motor neurone lesions and in Parkinsonism. J Neurol Sci 11:537–550

    Google Scholar 

  26. Ellis KO, Bryant SH (1972) Excitation contraction uncoupling in skeletal muscle by dantrolene sodium. Naunyn Schmiedebergs Arch Pharmacol 274:107–109

    Google Scholar 

  27. Feldman RG, Young RR, Koella WP (eds) (1980) Spasticity: disordered motor control. Symposia Specialists, Miami

    Google Scholar 

  28. Foley F (1961) The stiffness of spastic muscle. J Neurol Neurosurg Psychiatry 24:125–131

    Google Scholar 

  29. Freund H-J (1987) Abnormalities of motor behavior after cortical lesions in humans. In: Brooks V (ed) Handbook of physiology: The nervous system V. American Physiological Society, Bethesda, pp 763–810

    Google Scholar 

  30. Gage FH, Wictorin K, Fisher W, Williams LR, Varon S, Bjorklund A (1986) Retrograde cell changes in medial septum and diagonal band following fibria-fornix transection: quantitative temporal analysis. Neuroscience 19:241–255

    Google Scholar 

  31. Goldberger ME, Murray M (1988) Patterns of sprouting and implications for recovery of function. In: Waxman SG (ed) Advances in neurology, vol 47: Functional recovery in neurological disease. Raven Press, New York, pp 361–385

    Google Scholar 

  32. Hagbarth KE, Wallin G, Löfstedt L (1973) Muscle spindle responses to stretch in normal and spastic subjects. Scand J Rehabil Med 5:156–159

    Google Scholar 

  33. Hainaut K, Desmedt JE (1975) Effect of dantrolene sodium on calcium movements in single muscle fibres. Nature 286:728–729

    Google Scholar 

  34. Harrison NL (1990) On the presynaptic action of baclofen at inhibitory synapses between cultured rat hippocampal neurones. J Physiol (Lond) 422:433–446

    Google Scholar 

  35. Henatsch HD, Ingvar DH (1956) Chlorpromazin und Spastizität: eine experimentelle elektrophysiologische Untersuchung. Arch Psychiatr Nervenkr 195:77–93

    Google Scholar 

  36. Herman R (1970) The myotatic reflex: clinico-physiological aspects of spasticity and contracture. Brain 93:273–312

    Google Scholar 

  37. Hufschmidt A, Mauritz K-H (1985) Chronic transformation of muscle in spasticity: a peripheral contribution to increased tone. J Neurol Neurosurg Psychiatry 48:676–685

    Google Scholar 

  38. Hulsebosch CE, Coggeshall RE (1981) Sprouting of dorsal root axons. Brain Res 224:170–174

    Google Scholar 

  39. Iles JF, Roberts RC (1986) Presynaptic inhibition of monosynaptic reflexes in the lower limbs of subjects with upper motoneuron disease. J Neurol Neurosurg Psychiatry 49:937–944

    Google Scholar 

  40. Jami L, Murthy KSK, Petit J, Zytnicki D (1983) Action of dantrolene sodium on single motor units of cat muscle in vivo. Brain Res 261:285–294

    Google Scholar 

  41. Katz R, Pierrot-Deselligny E (1982) Recurrent inhibition of alpha-motoneurones in patients with upper motor neuron lesions. Brain 105:102–124

    Google Scholar 

  42. Kerr DJB, Ong J, Prager RH, Gynther BD, Curtis DR (1987) Phaclofen: a peripheral and central baclofen antagonist. Brain Res 405:150–154

    Google Scholar 

  43. Knutsson E, Richards C (1979) Different types of disturbed motor control in gait of hemiparetic patients. Brain 102:405–430

    Google Scholar 

  44. Lance JW (1980) The control of muscle tone, reflexes and movement: Robert Wartenberg Lecture. Neurology 30:1303–1313

    Google Scholar 

  45. Landau WM (1980) Spasticity: What is it? What is it not? In: Feldman RG, Young RR, Koella WP (eds) Spasticity: disordered motor control. Symposia Specialists, Miami, pp 17–24

    Google Scholar 

  46. Lawrence DG, Kuypers HGJM (1968) The functional organization of the motor system in the monkey. I. The effects of bilateral pyramidal lesions. Brain 91:1–14

    Google Scholar 

  47. Leslie GC, Part NJ (1981) The action of dantrolene sodium on rat fast and slow muscle in vivo. Br J Pharmacol 72:665–672

    Google Scholar 

  48. Liddell EGT, Sherrington CS (1924) Reflexes in response to stretch (myotatic reflexes). Proc R Soc Lond [Biol] 96:212–242

    Google Scholar 

  49. Mailis A, Ashby P (1990) Alternations in group Ia projections to motoneurons following spinal lesions in humans. J Neurophysiol 64:637–647

    Google Scholar 

  50. McCormick DA (1989) GABA as an inhibitory neurotransmitter in human cerebral cortex. J Neurophysiol 62:1018–1027

    Google Scholar 

  51. McCouch GP, Austin GM, Liu CN, Liu CY (1958) Sprouting as a cause of spasticity. J Neurophysiol 21:205–216

    Google Scholar 

  52. Meinck HM, Benecke R, Conrad B (1985) Spasticity and the flexor reflex. In: Delwaide PJ, Young RR (eds) Clinical neurophysiology in spasticity. Elsevier, Amsterdam, pp 41–54

    Google Scholar 

  53. Müller H, Zierski J, Dralle D, Börner U, Hoffmann O (1987) The effect of intrathecal baclofen on electrical muscle activity in spasticity. J Neurol 234:348–352

    Google Scholar 

  54. Murray M, Goldberger ME (1974) Restitution of function and collateral sprouting in the cat spinal cord: the partially hemisected animal. J Comp Neurol 158:19–36

    Google Scholar 

  55. Newberry NR, Nicoll RA (1984) Direct hyperpolarizing action of baclofen on hippocampal pyramidal cells. Nature 308:450–452

    Google Scholar 

  56. Newman PM, Nogues M, Newman PK, Weightman D, Hudgson P (1982) Tizanidine in the treatment of spasticity. Eur J Clin Pharmacol 23:31–35

    Google Scholar 

  57. Noth J (1988) Pharmacotherapy of spasticity. In: Müller H, Zierski J, Penn RD (eds) Local-spinal therapy of spasticity. Springer, Berlin Heidelberg New York, pp 93–96

    Google Scholar 

  58. Ochs G, Struppler A, Meyerson BA, Linderoth B, Gybels J, Gardner BP, Teddy P, Jamous A, Weinmann P (1989) Intrathecal baclofen for long-term treatment of spasticity: a multicentre study. J Neurol Neurosurg Psychiatry 52:933–939

    Google Scholar 

  59. Penn RD, Kroin JS (1985) Continuous intrathecal baclofen for severe spasticity. Lancet II:125–127

    Google Scholar 

  60. Polc P (1985) 2-amino-7-phosphonoheptanoic acid depresses gamma-motoneurons and polysynaptic reflexes in the cat spinal cord. Eur J Pharmacol 117:387–389

    Google Scholar 

  61. Powers RK, Marder-Meyer OT, Rymer WZ (1988) Quantitative relations between hypertonia and stretch reflex threshold in spastic hemiparesis. Ann Neurol 23:115–124

    Google Scholar 

  62. Powers RK, Campbell DL, Rymer WZ (1989) Stretch reflex dynamics in spastic elbow flexor muscles. Ann Neurol 25:32–42

    Google Scholar 

  63. Rack PMH, Ross HF, Thilmann AF (1984) The ankle stretch reflexes in normal and spastic subjects. Brain 107:637–654

    Google Scholar 

  64. Raisman G (1969) Neuronal plasticity in the septal nuclei of the adult rat. Brain Res 14:25–48

    Google Scholar 

  65. Rinne UK (1980) Tizanidine treatment of spasticity in multiple sclerosis and chronic myelopathy. Curr Ther Res 28:827–836

    Google Scholar 

  66. Robertson B, Taylor WR (1986) Effects of gamma-aminobutyric acid and (—)-baclofen on calcium and potassium currents in cat dorsal root ganglion neurones in vitro. Br J Pharmacol 89:661–672

    Google Scholar 

  67. Rodin BE, Kruger L (1984) Absence of intraspinal sprouting in dorsal root axons caudal to a partial spinal hemisection: a horseradish peroxidase transport study. Somatosens Res 2:171–192

    Google Scholar 

  68. Rondot P, Dalloz JC, Tardieu G (1958) Mesure de la force des reactions musculares à l'étirement passif au cours des raideurs pathologiques par lésions cérébrales. Rev Fr Etud Clin Biol 3:585–592

    Google Scholar 

  69. Rymer WZ, Houk JC, Crago PE (1979) Mechanisms of the clasp-knife reflex studied in an animal model. Exp Brain Res 37:93–113

    Google Scholar 

  70. Schwab ME (1990) Myelin-associated inhibitors of neurite growth. Exp Neurol 109:2–5

    Google Scholar 

  71. Schwarz M, Klockgether T, Turski L, Sontag K-H (1988) Intrathecal injection of antispastic drugs in rats: muscle relaxant action of midazolam, baclofen, 2-aminophosphonoheptanoic acid (AP 7) and tizanidine. In: Müller H, Zierski J, Penn RD (eds) Local spinal therapy of spasticity. Springer, Berlin Heidelberg New York, pp 65–79

    Google Scholar 

  72. Sherrington CS (1939) Phil Trans 190 B, 1898. Reprinted in: Denny-Brown D (ed) Hamish Hamilton, London, p 152

  73. Stirling JM, Cross AJ, Robinson TN, Green AR (1989) The effects of GABAB receptor agonists and antagonists on potassium-stimulated [Ca2+] in rat brain synaptosomes. Neuropharmacology 28:699–704

    Google Scholar 

  74. Thilmann AF, Fellows SJ, Garms E (1990) Pathological stretch reflexes on the ”good“ side of hemiparetic patients. J Neurol Neurosurg Psychiatry 53:208–214

    Google Scholar 

  75. Thilmann AF, Fellows SJ, Garms E (1991) The mechanism of spastic muscle hypertonus: variation in reflex gain over the time course of spasticity. Brain 114:233–244

    Google Scholar 

  76. Tower SS (1940) Pyramidal lesion in the monkey. Brain 63:36–90

    Google Scholar 

  77. Turski L, Schwarz M, Turski WA, Klockgether T, Sontag K-H, Collins JF (1985) Muscle relaxant action of excitatory amino acid antagonists. Neurosci Lett 53:321–326

    Google Scholar 

  78. Turski L, Klockgether T, Turski WA, Ikonomidou C, Schwarz M, Sontag K-H (1988) Muscle relaxant action of excitatory amino acid antagonists: sites of action. In: Cavalheiro EA, Lehrmann J, Turski L (eds) Frontiers in excitatory amino acid research. Liss, New York, pp 343–350

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologische Klinik mit klinischer Neurophysiologie, Alfried Krupp Hospital, Alfried Krupp-Strasse 21, W-4300, Essen, Federal Republic of Germany

    J. Noth

Authors
  1. J. Noth
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Noth, J. Trends in the pathophysiology and pharmacotherapy of spasticity. J Neurol 238, 131–139 (1991). https://doi.org/10.1007/BF00319679

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00319679

Key words

Search

Navigation